When someone is hit with a rare disease, they need more help than the person who is affected with a disease that everyone knows about and that has been treated many times before. Amicus Therapeutics is the kind of company that focuses on the rare diseases, and that offers help to those who are dealing with such issues (Facebook). Those who are faced with rare diseases and in need of some help in addressing what they are facing can rely on Amicus Therapeutics and the kind of aid that they are ready to give.
Amicus Therapeutics is based in Cranbury, New Jersey, and they have a goal of helping people around the country with the illnesses that they are facing. This is a biopharmaceutical company (https://finance.yahoo.com/quote/FOLD?ltr=1). The CEO of this endeavor is John Crowley. This company is something that has been around for a while now, and it is one that has bright things in front of it.
Amicus Therapeutics received a helpful grant to provide them with the money that they need for the plans that they have. This grant was something that helped them to get by a little longer, and that will push them on to a better future. The grant that Amicus Therapeutics received came through The Michael J. Fox Foundation. This grant was given to Amicus Therapeutics to help them with studies that they are completing in conjunction with David Geffen School of Medicine at UCLA. They also received another grant from the Alzheimers Drug Discovery Foundation to help with other research projects that they are working on.
Founded in 2002, Amicus Therapeutics is a company that is looking to help with the development and availability of drugs for those who are facing rare diseases and in need of someone to notice them and help them move on.